Deucravacitinib

Our Deucravacitinib intermediates are developed to meet stringent global standards for Active Pharmaceutical Ingredients (APIs). Manufactured using advanced synthesis routes and precise quality control, they enable efficient, high-yield production of Deucravacitinib. With scalable and reproducible processes, we ensure consistent purity and stability from lab-scale development to commercial manufacturing. Each intermediate is optimized for process efficiency, regulatory compliance, and reliable performance in formulation. Partnering with SSPharma gives you access to high-quality Deucravacitinib intermediates that support faster development cycles, robust supply chains, and seamless transition from R&D to large-scale production.

Deucravacitinib - Intermediate

Intermediate image

Name of Intermediate: ethyl 4,6-dichloropyridazine-3-carboxylate

Name of API: Deucravacitinib

CAS No: 679406-03-2

Deucravacitinib - Intermediate

Intermediate image

Name of Intermediate: lithium 4,6-dichloropyridazine-3-carboxylate

Name of API: Deucravacitinib

CAS No: 2245238-80-4

Deucravacitinib - Intermediate

Intermediate image

Name of Intermediate: 4,6-dichloropyridazine-3-carboxylic acid

Name of API: Deucravacitinib

CAS No: 1040246-87-4

Deucravacitinib - Intermediate

Intermediate image

Name of Intermediate: 2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)aniline

Name of API: Deucravacitinib

CAS No: 1609394-10-6

Deucravacitinib - Intermediate

Intermediate image

Name of Intermediate: 6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]pyridazine-3-carboxylic acid

Name of API: Deucravacitinib

CAS No: 2245111-18-4